About
Andrea Fagiolini, MD, is affiliated with the Dipartimento di Medicina Molecolare e dello Sviluppo and the Dipartimento di Psichiatria at the University of Siena, Italy. With publications spanning from 2002 to 2022, Fagiolini has contributed extensively to research on bipolar disorder, major depressive disorder, and related metabolic and cardiovascular comorbidities. The work includes studies on pharmacologic treatments, patient care, suicide risk, and the impact of COVID-19 in psychiatric settings. Fagiolini has frequently collaborated with authors such as Ellen Frank and David J. Kupfer.
